Occupational exposures are associated with worse morbidity in patients with COPD

Size: px
Start display at page:

Download "Occupational exposures are associated with worse morbidity in patients with COPD"

Transcription

1 Occupational exposures are associated with worse morbidity in patients with COPD Laura M Paulin 1, Gregory B Diette 1,2, Paul D Blanc 3, Nirupama Putcha 1, Mark D Eisner 4, Richard E Kanner 5, Andrew J Belli 1, Stephanie Christenson 6, Donald P Tashkin 7, MeiLan Han 8, R Graham Barr 8, Nadia N Hansel 1,2 for the SPIROMICS Research Group Online Data Supplement

2 Full Methods: Study population SPIROMICS is a multicenter prospective cohort study aiming to identify new COPD subgroups and intermediate markers of disease progression that predict longterm clinical endpoints of morbidity. The SPIROMICS cohort included smokers with and without COPD. A smaller group of non-smoking controls was recruited into SPIROMICS, although this group was not included in this analysis of smokers. Participants in SPIROMICS with COPD were years old with at least a 20 pack-year smoking history, and had a ratio of the post-bronchodilator forced expiratory volume in one second over the forced vital capacity (FEV 1 /FVC) of less than Smokers without COPD were within the same age range and had at least a 20 pack year smoking history, a post-bronchodilator FEV 1 /FVC ratio of>0.70 and an FVC greater than the lower limit of normal (E1). Exclusion criteria included a diagnosis of other obstructive lung diseases besides asthma, BMI >40 kg/m 2, history of lung cancer, and diagnosis of unstable cardiovascular disease. The study and additional exclusion criteria have been previously described (E2). The current study is a cross-sectional analysis of baseline data from the first 1075 participants (n=354 smokers without COPD and 721 smokers with COPD) who had complete occupational exposure data available for analysis. At the baseline visit, trained staff collected extensive demographic and clinical data from participants. Smoking history was determined by current smoking status, defined as whether the participant reporting smoking within the last month, and lifetime cumulative pack years of smoking. COPD outcomes Validated questionnaires assessed participants health-related quality of life (HRQOL) using a respiratory-specific HRQOL measure (St. George s Respiratory Questionnaire [SGRQ] total score (E3)) and a generic HRQOL instrument (Short-Form Health Survey [SF-12] physical component scale) (E4)). We also assessed COPD health-related status using the COPD Assessment Test ([CAT] (E5)) and dyspnea using the Modified Medical Research Council Dyspnea Scale ([mmrc] (E6)). Participant- E2

3 reported COPD exacerbations over twelve months were defined by 1) worsening respiratory symptoms requiring additional antibiotics or steroids, or 2) those requiring health care utilization (HCU) (visit to doctor s office, urgent care facility, emergency room, or hospital); for analytic purposes, they were dichotomized to define yes as any exacerbation over the past 12 months. Each participant performed spirometry, including pre-and post-bronchodilator FEV 1 % predicted according to standard procedures (E1, E7). In addition, the Six Minute Walk Test (6MWT) was performed under supervision of trained clinical staff (E8). Occupational exposure Occupational history was obtained using an interviewer-administered semistructured questionnaire. The longest held job was documented using free text entry, assigned a 2000 Census code by a single reviewer, and if unclear, was reviewed by two separate authors and adjudicated by a third. Risk of occupational exposures based on the longest job census code was determined by a previously published Job Exposure Matrix (JEM) specific for COPD (jobs classified as not exposed, intermediate exposure, or high exposure likelihood) (E9). Self-reported exposure to vapors, gas, dust or fumes (VGDF) has also been used to assess occupational exposure, and has been shown to perform well in comparison to a JEM approach (E10). In SPIROMICS, self-reported occupational exposure was ascertained by the following question: Did this [longest held] job expose you to vapors, gas, dust or fumes? Statistical Analysis We used descriptive statistics to characterize the patient population. Summary statistics were compared using chi-squared tests for proportions, and t-tests or Wilcoxon-Mann-Whitney tests for continuous data, as appropriate. As there were no significant differences in health outcomes between those with intermediate risk of occupational exposures and those with high risk as determined by the JEM (data not shown), intermediate and high exposure groups were combined to create a dichotomous JEM variable (intermediate/high risk of exposure vs. low risk of exposure), as has been done in prior studies (E10). Secondary analyses used E3

4 participant-reported exposure to VGDF as the metric of occupational exposure. We used multiple logistic regression analysis to determine the association between occupational exposures and the odds of COPD among all smokers. We re-tested this association in analyses stratified by current vs. former smoking status and by cumulative smoking above and below the median value of 45 pack years. In the subset of participants with established COPD, we used multiple linear and logistic regression analyses, as appropriate, to estimate the association between occupational exposure and COPD outcomes. All multivariate models included adjustment for age, race, sex, current smoking within the last month (yes/no), and total pack years as a continuous variable. Consistent with studies assessing occupational exposure on health outcomes (E9, E11, E12, E10, E13), we did not adjust for markers of socio-economic status (SES) in our main model, because this is a marker for, but not the cause of, occupational status and associated exposures, similar to the potential relationship of SES to cigarette smoking (E9). A mediation analysis, including post-bronchodilator FEV 1 % predicted as a covariate in multivariate models, was used to determine whether the effect of occupational exposure on health outcomes was independent of lung function. Similar analyses included the addition of income to the model. Secondary analysis included adjustment for medication use (long-acting inhaled bronchodilators within the last three months, inhaled corticosteroids within in the last three months, or current use of oral corticosteroids). Similarly, the role of comorbidities was assessed using the comorbidity score (a count of the number of comorbidities), a validated tool used to quantify comorbidity burden (E14). Additional analyses were also conducted that defined COPD as FEV 1 /FVC ratio<lower limit of normal (LLN) (E1). Interaction terms were tested to determine whether sex or smoking status (current smoking and pack years) modified the effect of occupational exposures on health outcomes. We further stratified analyses by sex and smoking status (current smoker vs. former smoker and, in a separate stratification, above vs. below median number of smoking pack years) for each of the linear and logistic regression models. All analyses were performed with StataMP statistical software, version 12.1 (StataCorp, College Station, TX). Statistical E4

5 significance was defined as a p-value of <0.05 for main effects as well as interaction terms. E5

6 Table E1: Multivariate analyses of effect of occupational exposure (JEM) on COPD health outcomes: Addition of Comorbidity Index Multivariate model * Addition of Comorbidity index to model β 95% CI p β 95% CI p Severity 6MWT distance (m) , , Post bronchodilator FEV 1 % predicted , , mmrc , , CAT , , HRQOL SGRQ , , SF-12 Physical , -1.6 < , -1.5 < Exacerbations OR 95% CI p Requiring HCU , , Requiring Meds , , Definition of abbreviations: JEM=Job Exposure Matrix; SD=Standard deviation; IQR=Interquartile range; 6MWT=Six Minute Walk Test; m=meters; FEV 1 =forced expiratory volume in 1 second; mmrc= Modified Medical Research Council Dyspnea Scale; CAT=COPD Assessment Test; HRQOL=Health related quality of life; SGRQ= St. George s Respiratory Questionnaire; SF-12 Physical= Short-Form Health Survey physical component scale; HCU=health care utilization. * Model adjusted for age, sex, race, current smoking status, pack years smoking Model adjusted for age, sex, race, current smoking status, pack years smoking and Comorbidity Index Table E2: Multivariate analyses of effect of occupational exposure (JEM) on COPD health outcomes: Fixed ratio vs. LLN definition of COPD Multivariate model using FEV/FVC < 0.7 to define COPD * n=721 Multivariate model using FEV/FVC LLN to define COPD * n=595 β 95% CI p β 95% CI p Severity 6MWT distance (m) , , Post bronchodilator FEV 1 % predicted , , mmrc , , CAT , , HRQOL SGRQ , , SF-12 Physical , -1.6 < , Exacerbations OR 95% CI P OR 95% CI P Requiring HCU , , Requiring Meds , , Definition of abbreviations: JEM=Job Exposure Matrix; SD=Standard deviation; IQR=Interquartile range; 6MWT=Six Minute Walk Test; m=meters; FEV 1 =forced E6

7 expiratory volume in 1 second; mmrc= Modified Medical Research Council Dyspnea Scale; CAT=COPD Assessment Test; HRQOL=Health related quality of life; SGRQ= St. George s Respiratory Questionnaire; SF-12 Physical= Short-Form Health Survey physical component scale; HCU=health care utilization. * Model adjusted for age, sex, race, current smoking status, pack years smoking Table E3: Multivariate analyses of effect of occupational exposure (VGDF) on COPD health outcomes Multivariate model * Addition of post-bronchodilator FEV 1 % predicted to model n=721 n=721 β 95% CI p β 95% CI p Severity 6MWT distance (m) , , Post bronchodilator FEV 1 % predicted , , mmrc , , CAT , , HRQOL SGRQ , , SF-12 Physical , , Exacerbations OR 95% CI p OR 95% CI p Requiring HCU , , Requiring Meds , , Definition of abbreviations: VGDF=self-report exposure to vapors, gas, dust and fumes; 6MWT=Six Minute Walk Test; m=meters; FEV 1 =forced expiratory volume in 1 second; mmrc= Modified Medical Research Council Dyspnea Scale; CAT=COPD Assessment Test; HRQOL=Health related quality of life; SGRQ= St. George s Respiratory Questionnaire; SF-12 Physical= Short-Form Health Survey physical component scale; HCU=health care utilization. * Model adjusted for age, sex, race, current smoking status, pack years smoking history Model adjusted for age, sex, race, current smoking status, pack years smoking and post bronchodilator FEV 1 % predicted. Post-bronchodilator FEV 1 % predicted not included in model predicting lung function. E7

8 Online Data Supplement References E1. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159: E2. Couper D, Lavange LM, Han M, Barr RG, Bleecker E, Hoffman EA, Kanner R, Kleerup E, Martinez FJ, Woodruff PG, Rennard S, for the SRG. Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS). Thorax 2014; 69: E3. Barr JT, Schumacher GE, Freeman S, LeMoine M, Bakst AW, Jones PW. American translation, modification, and validation of the St. George's Respiratory Questionnaire. Clin Ther 2000; 22: E4. Ware J, Jr., Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Medical care 1996; 34: E5. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J 2009; 34: 648. E6. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: E7. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005; 26: E8. ATS Statement: Guidelines for the Six-Minute Walk Test. Am J Respir Crit Care Med 2002; 166: E9. Trupin L, Earnest G, San Pedro M, Balmes JR, Eisner MD, Yelin E, Katz PP, Blanc PD. The occupational burden of chronic obstructive pulmonary disease. Eur Respir J 2003; 22: E10. Blanc PD, Eisner MD, Balmes JR, Trupin L, Yelin EH, Katz PP. Exposure to vapors, gas, dust, or fumes: assessment by a single survey item compared to a detailed exposure battery and a job exposure matrix. Am J Ind Med 2005; 48: 110. E11. Harber P, Tashkin DP, Simmons M, Crawford L, Hnizdo E, Connett J, Lung Health Study G. Effect of occupational exposures on decline of lung function in early chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 176: E8

9 E12. Rodriguez E, Ferrer J, Marti S, Zock JP, Plana E, Morell F. Impact of occupational exposure on severity of COPD. Chest 2008; 134: E13. Blanc PD, Eisner MD, Earnest G, Trupin L, Balmes JR, Yelin EH, Gregorich SE, Katz PP. Further exploration of the links between occupational exposure and chronic obstructive pulmonary disease. J Occup Env Med 2009; 51: 804. E14. Putcha N PM, Drummond MB, Han MK, Regan EA, Hanania NA, Martinez C, Bhatt SP, Make B, Ramsdell J, Demeo D, Foreman M, Barr RG, Rennard SI, Martinez F, Silverman EK, Crapo J, Wise RA, Hansel NN. A simplified score to quantify comorbidity in COPD. PloS one 2014; In press. E9

SGRQ Questionnaire assessing respiratory disease-specific quality of life. Questionnaire assessing general quality of life

SGRQ Questionnaire assessing respiratory disease-specific quality of life. Questionnaire assessing general quality of life SUPPLEMENTARY MATERIAL e-table 1: Outcomes studied in present analysis. Outcome Abbreviation Definition Nature of data, direction indicating adverse effect (continuous only) Clinical outcomes- subjective

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Woodruff PG, Barr RG, Bleecker E, et al. Clinical significance

More information

Clinical and radiographic predictors of GOLD-Unclassified smokers in COPDGene

Clinical and radiographic predictors of GOLD-Unclassified smokers in COPDGene Clinical and radiographic predictors of GOLD-Unclassified smokers in COPDGene Emily S. Wan, John E. Hokanson, James R. Murphy, Elizabeth A. Regan, Barry J. Make, David A. Lynch, James D. Crapo, Edwin K.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Regan EA, Lynch DA, Curran-Everett D, et al; Genetic Epidemiology of COPD (COPDGene) Investigators. Clinical and radiologic disease in smokers with normal spirometry. Published

More information

of Nebraska - Lincoln

of Nebraska - Lincoln University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln U.S. Department of Veterans Affairs Staff Publications U.S. Department of Veterans Affairs 2017 Respiratory Symptoms Items

More information

This is a cross-sectional analysis of the National Health and Nutrition Examination

This is a cross-sectional analysis of the National Health and Nutrition Examination SUPPLEMENTAL METHODS Study Design and Setting This is a cross-sectional analysis of the National Health and Nutrition Examination Survey (NHANES) data 2007-2008, 2009-2010, and 2011-2012. The NHANES is

More information

Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification

Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification ORIGINAL ARTICLE COPD Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification Paul W. Jones 1, Lukasz Adamek 2, Gilbert Nadeau 2 and Norbert Banik 3 Affiliations:

More information

A Validation Study for the Korean Version of Chronic Obstructive Pulmonary Disease Assessment Test (CAT)

A Validation Study for the Korean Version of Chronic Obstructive Pulmonary Disease Assessment Test (CAT) http://dx.doi.org/10.4046/trd.2013.74.6.256 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2013;74:256-263 CopyrightC2013. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights

More information

abstract n engl j med 374;19 nejm.org May 12,

abstract n engl j med 374;19 nejm.org May 12, The new england journal of medicine established in 1812 May 12, 2016 vol. 374 no. 19 Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function Prescott G. Woodruff, M.D., R. Graham

More information

Cigarette Smoking and Lung Obstruction Among Adults Aged 40 79: United States,

Cigarette Smoking and Lung Obstruction Among Adults Aged 40 79: United States, NCHS Data Brief No. 8 January 25 Cigarette Smoking and Lung Obstruction Among Adults Aged 4 79: United States, 27 22 Ryne Paulose-Ram, Ph.D., M.A.; Timothy Tilert, B.S.; Charles F. Dillon, M.D., Ph.D.;

More information

Manuscript type: Research letter

Manuscript type: Research letter TITLE PAGE Chronic breathlessness associated with poorer physical and mental health-related quality of life (SF-12) across all adult age groups. Authors Currow DC, 1,2,3 Dal Grande E, 4 Ferreira D, 1 Johnson

More information

Lung Function Basics of Diagnosis of Obstructive, Restrictive and Mixed Defects

Lung Function Basics of Diagnosis of Obstructive, Restrictive and Mixed Defects Lung Function Basics of Diagnosis of Obstructive, Restrictive and Mixed Defects Use of GOLD and ATS Criteria Connie Paladenech, RRT, RCP, FAARC Benefits and Limitations of Pulmonary Function Testing Benefits

More information

Occupational exposures and the risk of COPD: dusty trades revisited

Occupational exposures and the risk of COPD: dusty trades revisited 1 Division of Occupational and Environmental Medicine & Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, USA; 2 Division of Research, Kaiser

More information

QUALITY OF LIFE MEASURED BY THE ST GEORGE'S RESPIRATORY QUESTIONNAIRE AND SPIROMETRY

QUALITY OF LIFE MEASURED BY THE ST GEORGE'S RESPIRATORY QUESTIONNAIRE AND SPIROMETRY ERJ Express. Published on January 22, 2009 as doi: 10.1183/09031936.00116808 QUALITY OF LIFE MEASURED BY THE ST GEORGE'S RESPIRATORY QUESTIONNAIRE AND SPIROMETRY 1 Mark Weatherall, 2 Suzanne Marsh, 2 Philippa

More information

Decramer 2014 a &b [21]

Decramer 2014 a &b [21] Buhl 2015 [19] Celli 2014 [20] Decramer 2014 a &b [21] D Urzo 2014 [22] Maleki-Yazdi 2014 [23] Inclusion criteria: Diagnosis of chronic obstructive pulmonary disease; 40 years of age or older; Relatively

More information

Does the multidimensional grading system (BODE) correspond to differences in health status of patients with COPD?

Does the multidimensional grading system (BODE) correspond to differences in health status of patients with COPD? AUTHOR COPY ORIGINAL RESEARCH Does the multidimensional grading system (BODE) correspond to differences in health status of patients with COPD? Kian-Chung Ong 1 Suat-Jin Lu 1 Cindy Seok-Chin Soh 2 1 Department

More information

Spirometric protocol

Spirometric protocol Spirometric protocol Spirometry is the most common of the Pulmonary Function Test, that measures lung function, specifically the amount (volume) and/or speed (flow) of air that can be inhaled and exhaled.

More information

Outline FEF Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications?

Outline FEF Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications? Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications? Fernando Holguin MD MPH Director, Asthma Clinical & Research Program Center for lungs and Breathing University of Colorado

More information

Patient Assessment Quality of Life

Patient Assessment Quality of Life Patient Assessment Quality of Life STEP 1 Learning objectives This module will provide you with an understanding of the importance of assessing Quality of Life (QoL) in patients and the role that quality

More information

Impact of the new ATS/ERS pulmonary function test interpretation guidelines

Impact of the new ATS/ERS pulmonary function test interpretation guidelines Respiratory Medicine (2007) 101, 2336 2342 Impact of the new ATS/ERS pulmonary function test interpretation guidelines Mary Elizabeth Kreider a,, Michael A. Grippi a,b a Division of Pulmonary, Allergy,

More information

Using Spirometry to Rule Out Restriction in Patients with Concomitant Low Forced Vital Capacity and Obstructive Pattern

Using Spirometry to Rule Out Restriction in Patients with Concomitant Low Forced Vital Capacity and Obstructive Pattern 44 The Open Respiratory Medicine Journal, 2011, 5, 44-50 Using Spirometry to Rule Out Restriction in Patients with Concomitant Low Forced Vital Capacity and Obstructive Pattern Open Access Imran Khalid

More information

exacerbation has greater impact on functional status than frequency of exacerbation episodes.

exacerbation has greater impact on functional status than frequency of exacerbation episodes. Original Article Singapore Med J 2011, 52(12) 894 Changes in the BODE index, exacerbation duration and hospitalisation in a cohort of COPD patients Bu X N, Yang T, Thompson M A, Hutchinson A F, Irving

More information

SLEEPJ, 2018, 1 8. Original Article

SLEEPJ, 2018, 1 8. Original Article SLEEPJ, 2018, 1 8 doi: 10.1093/sleep/zsy044 Advance Access Publication Date: 9 March 2018 Original Article Original Article Sleep disruption as a predictor of quality of life among patients in the subpopulations

More information

Pulmonary Function Testing

Pulmonary Function Testing In the Clinic Pulmonary Function Testing Hawa Edriss MD, Gilbert Berdine MD The term PFT encompasses three different measures of lung function: spirometry, lung volumes, and diffusion capacity. In this

More information

Validity and Reliability of CAT and Dyspnea-12 in Bronchiectasis and Tuberculous Destroyed Lung

Validity and Reliability of CAT and Dyspnea-12 in Bronchiectasis and Tuberculous Destroyed Lung http://dx.doi.org/10.4046/trd.2012.72.6.467 ISSN: 1738-3536(Print)/2005-6184(Online) Tuberc Respir Dis 2012;72:467-474 CopyrightC2012. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Calverley P M A, Anzueto A R, Carter K, et

More information

Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index

Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index Chronic Respiratory Disease 2009; 6: 75 80 http://crd.sagepub.com ORIGINAL PAPER Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index

More information

THE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable

THE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable THE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable This activity is supported by an educational grant from Sunovion Pharmaceuticals Inc. COPD in the United States Third leading cause

More information

Int. J. Pharm. Sci. Rev. Res., 34(2), September October 2015; Article No. 24, Pages: Role of Spirometry in Diagnosis of Respiratory Diseases

Int. J. Pharm. Sci. Rev. Res., 34(2), September October 2015; Article No. 24, Pages: Role of Spirometry in Diagnosis of Respiratory Diseases Review Article Role of Spirometry in Diagnosis of Respiratory Diseases Dipti Mohapatra 1, Tapaswini Mishra 1, Manasi Behera 1, Nibedita Priyadarsini 1, Arati Mohanty 1, *Prakash Kumar Sasmal 2 1 Department

More information

9/22/2015 CONFLICT OF INTEREST OBJECTIVES. Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR

9/22/2015 CONFLICT OF INTEREST OBJECTIVES. Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR by Scott Cerreta, BS, RRT Director of Education www.copdfoundation.org scerreta@copdfoundation.org CONFLICT OF INTEREST

More information

Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR

Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR by Scott Cerreta, BS, RRT Director of Education www.copdfoundation.org scerreta@copdfoundation.org CONFLICT OF INTEREST

More information

Blood Eosinophils and Response to Maintenance COPD Treatment: Data from the FLAME Trial. Online Data Supplement

Blood Eosinophils and Response to Maintenance COPD Treatment: Data from the FLAME Trial. Online Data Supplement Blood Eosinophils and Response to Maintenance COPD Treatment: Data from the FLAME Trial Nicolas Roche, Kenneth R. Chapman, Claus F. Vogelmeier, Felix JF Herth, Chau Thach, Robert Fogel, Petter Olsson,

More information

Heterogeneous burden of lung disease in smokers with borderline airflow obstruction

Heterogeneous burden of lung disease in smokers with borderline airflow obstruction Pirozzi et al. Respiratory Research (2018) 19:223 https://doi.org/10.1186/s12931-018-0911-z RESEARCH Open Access Heterogeneous burden of lung disease in smokers with borderline airflow obstruction Cheryl

More information

Assessment of Bronchodilator Response in Various Spirometric Patterns

Assessment of Bronchodilator Response in Various Spirometric Patterns Original Article 2013 NRITLD, National Research Institute of Tuberculosis and Lung Disease, Iran ISSN: 1735-0344 TANAFFOS Assessment of Bronchodilator Response in Various Spirometric Patterns Amir Houshang

More information

TORCH: Salmeterol and Fluticasone Propionate and Survival in COPD

TORCH: Salmeterol and Fluticasone Propionate and Survival in COPD TORCH: and Propionate and Survival in COPD April 19, 2007 Justin Lee Pharmacy Resident University Health Network Outline Overview of COPD Pathophysiology Pharmacological Treatment Overview of the TORCH

More information

C hronic obstructive pulmonary disease (COPD) is one of

C hronic obstructive pulmonary disease (COPD) is one of 589 RESPIRATORY INFECTIONS Time course of recovery of health status following an infective exacerbation of chronic bronchitis S Spencer, P W Jones for the GLOBE Study Group... Thorax 2003;58:589 593 See

More information

Douglas W. Mapel MD, MPH, Melissa Roberts PhD

Douglas W. Mapel MD, MPH, Melissa Roberts PhD Original Article Spirometry, the St. George s Respiratory Questionnaire, and other clinical measures as predictors of medical costs and COPD exacerbation events in a prospective cohort Douglas W. Mapel

More information

Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease

Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease Thorax 1999;54:581 586 581 Academic Department of Respiratory Medicine, St Bartholomew s and Royal London School of Medicine and Dentistry, London Chest Hospital, London, UK EAPaul R Garrod R Garnham J

More information

Predictive Models of Emphysema Progression in HIV

Predictive Models of Emphysema Progression in HIV Predictive Models of Emphysema Progression in HIV Janice Leung, MD FRCPC A. Malagoli, A. Santoro, G. Besutti, G. Ligabue, D. Dai, J. Mayo, S. Lam, D. Sin, S. Man, G. Guaraldi COPD: An Emerging Comorbidity

More information

Validation of the new COPD assessment test translated into Thai in patients with chronic obstructive pulmonary disease

Validation of the new COPD assessment test translated into Thai in patients with chronic obstructive pulmonary disease Pothirat et al. BMC Pulmonary Medicine 2014, 14:193 RESEARCH ARTICLE Open Access Validation of the new COPD assessment test translated into Thai in patients with chronic obstructive pulmonary disease Chaicharn

More information

UNDERSTANDING COPD MEDIA BACKGROUNDER

UNDERSTANDING COPD MEDIA BACKGROUNDER UNDERSTANDING COPD MEDIA BACKGROUNDER What is COPD? Chronic Obstructive Pulmonary Disease (COPD) also called emphysema and/or chronic obstructive bronchitis* is a preventable lung disease caused by the

More information

Productivity losses in chronic obstructive pulmonary disease a population-based survey.

Productivity losses in chronic obstructive pulmonary disease a population-based survey. Online supplement to Productivity losses in chronic obstructive pulmonary disease a population-based survey. Running head: Productivity losses in COPD. Authors: Marta Erdal, Department of Thoracic Medicine,

More information

Journal of the COPD Foundation

Journal of the COPD Foundation 132 Predictors of Change in SGRQ Score Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation Original Research Baseline Severity as Predictor of Change in St George s Respiratory Questionnaire

More information

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable: The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

compare patients preferences and costs for asthma treatment regimens targeting three

compare patients preferences and costs for asthma treatment regimens targeting three APPENDIX I ADDITIONAL METHODS Trial design The Accurate trial lasted from September 2009 until January 2012 and was designed to compare patients preferences and costs for asthma treatment regimens targeting

More information

Occupational airborne exposure in relation to Chronic Obstructive Pulmonary Disease

Occupational airborne exposure in relation to Chronic Obstructive Pulmonary Disease Occupational airborne exposure in relation to Chronic Obstructive Pulmonary Disease (COPD) and lung function in individuals without childhood wheezing illness: a 50-year cohort study Nara Tagiyeva 1, PhD,

More information

Effect Of Byrates (Barium Sulphate) On Pulmonary Function In Byrates Mine Workers

Effect Of Byrates (Barium Sulphate) On Pulmonary Function In Byrates Mine Workers IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 17, Issue 01 Ver. I January. (2018), PP 46-50 www.iosrjournals.org Effect Of Byrates (Barium Sulphate)

More information

Bronchodilator responsiveness in patients with COPD

Bronchodilator responsiveness in patients with COPD Eur Respir J 28; 31: 742 75 DOI: 1.1183/931936.12967 CopyrightßERS Journals Ltd 28 Bronchodilator responsiveness in patients with COPD D.P. Tashkin*, B. Celli #, M. Decramer ", D. Liu +, D. Burkhart +,

More information

Life-long asthma and its relationship to COPD. Stephen T Holgate School of Medicine University of Southampton

Life-long asthma and its relationship to COPD. Stephen T Holgate School of Medicine University of Southampton Life-long asthma and its relationship to COPD Stephen T Holgate School of Medicine University of Southampton Definitions COPD is a preventable and treatable disease with some significant extrapulmonary

More information

Persistent Empiric COPD Diagnosis and Treatment After Pulmonary Function Test Showed No Obstruction

Persistent Empiric COPD Diagnosis and Treatment After Pulmonary Function Test Showed No Obstruction Persistent Empiric COPD Diagnosis and Treatment After Pulmonary Function Test Showed No Obstruction Spyridon Fortis MD, Edward O Corazalla MSc RPFT, David R Jacobs Jr PhD, and Hyun J Kim MD BACKGROUND:

More information

COPD in Helsinki, Finland: socioeconomic status based on occupation has an important impact on prevalence

COPD in Helsinki, Finland: socioeconomic status based on occupation has an important impact on prevalence https://helda.helsinki.fi COPD in Helsinki, Finland: socioeconomic status based on occupation has an important impact on prevalence Kainu, Annette 2013-08 Kainu, A, Rouhos, A, Sovijärvi, A, Lindqvist,

More information

The distribution of COPD in UK general practice using the new GOLD classification

The distribution of COPD in UK general practice using the new GOLD classification ERJ Express. Published on October 31, 2013 as doi: 10.1183/09031936.00065013 The distribution of COPD in UK general practice using the new GOLD classification John Haughney 1, Kevin Gruffydd-Jones 2, June

More information

JOINT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MANAGEMENT GUIDELINES

JOINT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MANAGEMENT GUIDELINES JOINT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MANAGEMENT GUIDELINES Authors Dr Ian Benton Respiratory Consultant COCH Penny Rideal Respiratory Nurse COCH Kirti Burgul Respiratory Pharmacist COCH Pam

More information

T he recent international guidelines from the Global

T he recent international guidelines from the Global 842 CHRONIC OBSTRUCTIVE PULMONARY DISEASE Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study A Johannessen, E R Omenaas, P

More information

Development and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire*

Development and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire* Original Research COPD Development and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire* Makiko Meguro, Mphil; Elizabeth A. Barley, PhD, CPsychol; Sally Spencer,

More information

Welding fume exposure and chronic obstructive pulmonary disease in welders

Welding fume exposure and chronic obstructive pulmonary disease in welders Occupational Medicine 2015;65:72 77 Advance Access publication 16 October 2014 doi:10.1093/occmed/kqu136 Welding fume exposure and chronic obstructive pulmonary disease in welders D.-H. Koh, 1 J.-I. Kim,

More information

COPD-Related Musculoskeletal Disease. Jessica Bon Field, MD, MS 2017 Update in Internal Medicine October 20, 2017

COPD-Related Musculoskeletal Disease. Jessica Bon Field, MD, MS 2017 Update in Internal Medicine October 20, 2017 COPD-Related Musculoskeletal Disease Jessica Bon Field, MD, MS 2017 Update in Internal Medicine October 20, 2017 A 60-year old man with COPD comes into your office for a routine office visit. He is a former

More information

Peian Lou 1*, Yanan Zhu 2, Peipei Chen 1, Pan Zhang 1, Jiaxi Yu 1, Ning Zhang 1, Na Chen 1, Lei Zhang 1, Hongmin Wu 2 and Jing Zhao 2

Peian Lou 1*, Yanan Zhu 2, Peipei Chen 1, Pan Zhang 1, Jiaxi Yu 1, Ning Zhang 1, Na Chen 1, Lei Zhang 1, Hongmin Wu 2 and Jing Zhao 2 Lou et al. BMC Pulmonary Medicine 2012, 12:53 RESEARCH ARTICLE Open Access Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease

More information

Clinical determinants of exacerbations in severe, early-onset COPD

Clinical determinants of exacerbations in severe, early-onset COPD Eur Respir J 2007; 30: 1124 1130 DOI: 10.1183/09031936.00009307 CopyrightßERS Journals Ltd 2007 Clinical determinants of exacerbations in severe, early-onset COPD M.G. Foreman*, D.L. DeMeo*,#, C.P. Hersh*,#,

More information

What s new in COPD? Apichart Khanichap MD. Department of Medicine, Faculty of Medicine, Thammasat university

What s new in COPD? Apichart Khanichap MD. Department of Medicine, Faculty of Medicine, Thammasat university What s new in COPD? Apichart Khanichap MD. Department of Medicine, Faculty of Medicine, Thammasat university Management stable COPD Relieve symptoms Improve exercise tolerance Improve health status Prevent

More information

Evaluating Spirometric Trends in Cystic Fibrosis Patients

Evaluating Spirometric Trends in Cystic Fibrosis Patients Evaluating Spirometric Trends in Cystic Fibrosis Patients S. Zarei, M. Abouali, A. Mirtar, J. Redfield, D. Palmer and D. J. Conrad P. Salamon, Computational Science Research Center, San Diego State University

More information

Turning Science into Real Life Roflumilast in Clinical Practice. Roland Buhl Pulmonary Department Mainz University Hospital

Turning Science into Real Life Roflumilast in Clinical Practice. Roland Buhl Pulmonary Department Mainz University Hospital Turning Science into Real Life Roflumilast in Clinical Practice Roland Buhl Pulmonary Department Mainz University Hospital Therapy at each stage of COPD I: Mild II: Moderate III: Severe IV: Very severe

More information

COPD, Asthma, Or Something In Between? Sharon R. Rosenberg Assistant Professor of Medicine Northwestern University December 4, 2013

COPD, Asthma, Or Something In Between? Sharon R. Rosenberg Assistant Professor of Medicine Northwestern University December 4, 2013 COPD, Asthma, Or Something In Between? Sharon R. Rosenberg Assistant Professor of Medicine Northwestern University December 4, 2013 None Disclosures Definitions Asthma Asthma is a chronic inflammatory

More information

2/4/2019. GOLD Objectives. GOLD 2019 Report: Chapters

2/4/2019. GOLD Objectives. GOLD 2019 Report: Chapters GOLD Objectives To provide a non biased review of the current evidence for the assessment, diagnosis and treatment of patients with COPD. To highlight short term and long term treatment objectives organized

More information

Treatment Responses. Ronald Dahl, Aarhus University Hospital, Denmark

Treatment Responses. Ronald Dahl, Aarhus University Hospital, Denmark Asthma and COPD: Are They a Spectrum Treatment Responses Ronald Dahl, Aarhus University Hospital, Denmark Pharmacological Treatments Bronchodilators Inhaled short-acting β -Agonist (rescue) Inhaled short-acting

More information

C hronic obstructive pulmonary disease (COPD) is one of

C hronic obstructive pulmonary disease (COPD) is one of 935 CHRONIC OBSTRUCTIVE PULMONARY DISEASE Developing COPD: a 25 year follow up study of the general population A Løkke, P Lange, H Scharling, P Fabricius, J Vestbo... See end of article for authors affiliations...

More information

Goals. Occupational COPD and Chronic Bronchitis. Case History. Smoking History. Patient presents at age 68. Active cigarette smoker, age 14-30

Goals. Occupational COPD and Chronic Bronchitis. Case History. Smoking History. Patient presents at age 68. Active cigarette smoker, age 14-30 Occupational COPD and Chronic Bronchitis Occupational and Environmental Respiratory Disease UCSF March 2016 Paul D. Blanc MD MSPH University of California San Francisco Division of Occupational and Environmental

More information

Key words: COPD, prediction, pulmonary rehabilitation, response.

Key words: COPD, prediction, pulmonary rehabilitation, response. ERJ Express. Published on February 15, 2006 as doi: 10.1183/09031936.06.00130605 1 Predictors of Success and Failure in Pulmonary Rehabilitation Short title: Success and Failure in pulmonary rehabilitation

More information

Available online at Scholars Research Library

Available online at   Scholars Research Library Available online at www.scholarsresearchlibrary.com Annals of Biological Research, 2010, 1 (4) : 248-253 (http://scholarsresearchlibrary.com/archive.html) ISSN 0976-1233 CODEN (USA): ABRNBW A study on

More information

Online Data Supplement. Prevalence of Chronic Obstructive Pulmonary Disease in Korea: Results of a Population-based Spirometry Survey

Online Data Supplement. Prevalence of Chronic Obstructive Pulmonary Disease in Korea: Results of a Population-based Spirometry Survey Online Data Supplement Prevalence of Chronic Obstructive Pulmonary Disease in Korea: Results of a Population-based Spirometry Survey Dong Soon Kim, MD, Young Sam Kim MD, Kee Suk Chung MD, Jung Hyun Chang

More information

Disclosures. Chronic Obstructive Pulmonary Disease. Chronic Obstructive Pulmonary Disease (COPD)

Disclosures. Chronic Obstructive Pulmonary Disease. Chronic Obstructive Pulmonary Disease (COPD) Chronic Obstructive Pulmonary Disease May 14, 2016 Orlando, FL COPD (Chronic obstructive pulmonary disease) is a major cause of mortality and morbidity in the United States. Alarmingly, COPD recently became

More information

Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial

Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial Eur Respir J 2010; 35: 287 294 DOI: 10.1183/09031936.00082909 CopyrightßERS Journals Ltd 2010 Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial D.P. Tashkin*, B. Celli

More information

Effect of smoking on lung function, respiratory symptoms and respiratory diseases amongst HIV-positive subjects: a cross-sectional study

Effect of smoking on lung function, respiratory symptoms and respiratory diseases amongst HIV-positive subjects: a cross-sectional study RESEARCH Open Access Effect of smoking on lung function, respiratory symptoms and respiratory diseases amongst HIV-positive subjects: a cross-sectional study Qu Cui 1*, Sue Carruthers 2, Andrew McIvor

More information

Relationship between Methacholine Challenge Testing and exhaled Nitric Oxide in adult patients with suspected bronchial asthma

Relationship between Methacholine Challenge Testing and exhaled Nitric Oxide in adult patients with suspected bronchial asthma O R I G I N A L A R T I C L E S Eur Ann Allergy Clin Immunol Vol 46, N 3, 109-113, 2014 M. Giovannini, M. Valli, V. Ribuffo, R. Melara, G. Cappiello, E. Businarolo, A. Andreani Relationship between Methacholine

More information

COPD: A Renewed Focus. Disclosures

COPD: A Renewed Focus. Disclosures COPD: A Renewed Focus Heath Latham, MD Assistant Professor Division of Pulmonary and Critical Care Medicine Disclosures No Business Interests No Consulting No Speakers Bureau No Off Label Use to Discuss

More information

Outcomes and health-related quality of life following hospitalization for an acute exacerbation of COPD

Outcomes and health-related quality of life following hospitalization for an acute exacerbation of COPD Blackwell Science, LtdOxford, UKRESRespirology1323-77992005 Blackwell Publishing Asia Pty LtdSeptember 2005103334340Original ArticleHospitalization and COPDQ Wang and J Bourbeau Respirology (2005) 10,

More information

Update on heterogeneity of COPD, evaluation of COPD severity and exacerbation

Update on heterogeneity of COPD, evaluation of COPD severity and exacerbation Update on heterogeneity of COPD, evaluation of COPD severity and exacerbation Yung-Yang Liu, MD Taipei Veterans General Hospital Aug 29, 2015 G O lobal Initiative for Chronic bstructive L D ung isease

More information

The distribution of COPD in UK general practice using the new GOLD classification

The distribution of COPD in UK general practice using the new GOLD classification ORIGINAL ARTICLE COPD The distribution of COPD in UK general practice using the new GOLD classification John Haughney 1, Kevin Gruffydd-Jones 2, June Roberts 3, Amanda J. Lee 4, Alison Hardwell 5 and Lorcan

More information

Chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease 0 Chronic obstructive pulmonary disease Implementing NICE guidance June 2010 NICE clinical guideline 101 What this presentation covers Background Scope Key priorities for implementation Discussion Find

More information

Pulmonary Adverse Effects of Welding Fume in Automobile Assembly Welders

Pulmonary Adverse Effects of Welding Fume in Automobile Assembly Welders ORIGINAL REPORT Pulmonary Adverse Effects of Welding Fume in Automobile Assembly Welders Seyed Akbar Sharifian 1, Ziba Loukzadeh 2, Ahmad Shojaoddiny-Ardekani 2, and Omid Aminian 1 1 Department of Occupational

More information

Bode index as a predictor of severity in patients with chronic obstructive pulmonary disease.

Bode index as a predictor of severity in patients with chronic obstructive pulmonary disease. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 5 Ver. VII (May. 2016), PP 93-100 www.iosrjournals.org Bode index as a predictor of severity

More information

Quality of Life and Related Factors in Patients with Chronic Obstructive Pulmonary Disease

Quality of Life and Related Factors in Patients with Chronic Obstructive Pulmonary Disease 51 Quality of Life and Related Factors in Patients with COPD ORIGINAL RESEARCH ARTICLE Tanaffos (2006) 5(3), 51-56 2006 NRITLD, National Research Institute of Tuberculosis and Lung Disease, Iran Quality

More information

Advances in the management of chronic obstructive lung diseases (COPD) David CL Lam Department of Medicine University of Hong Kong October, 2015

Advances in the management of chronic obstructive lung diseases (COPD) David CL Lam Department of Medicine University of Hong Kong October, 2015 Advances in the management of chronic obstructive lung diseases (COPD) David CL Lam Department of Medicine University of Hong Kong October, 2015 Chronic obstructive pulmonary disease (COPD) COPD in Hong

More information

Is there any correlation between the ATS, BTS, ERS and GOLD COPD s severity scales and the frequency of hospital admissions?

Is there any correlation between the ATS, BTS, ERS and GOLD COPD s severity scales and the frequency of hospital admissions? Respiratory Medicine (2004) 98, 178 183 Is there any correlation between the ATS, BTS, ERS and GOLD COPD s severity scales and the frequency of hospital admissions? Maria Tsoumakidou, Nikolaos Tzanakis,

More information

Birmingham COPD Cohort: a cross-sectional analysis of the factors associated with the likelihood of being in paid employment among people with COPD

Birmingham COPD Cohort: a cross-sectional analysis of the factors associated with the likelihood of being in paid employment among people with COPD International Journal of COPD open access to scientific and medical research Open Access Full Text Article Original Research Birmingham COPD Cohort: a cross-sectional analysis of the factors associated

More information

COPD: Current Medical Therapy

COPD: Current Medical Therapy COPD: Current Medical Therapy Angela Golden, DNP, FNP-C, FAANP Owner, NP from Home, LLC Outcomes As a result of this activity, learners will be able to: 1. List the appropriate classes of medications for

More information

Understanding the Basics of Spirometry It s not just about yelling blow

Understanding the Basics of Spirometry It s not just about yelling blow Understanding the Basics of Spirometry It s not just about yelling blow Carl D. Mottram, RRT RPFT FAARC Technical Director - Pulmonary Function Labs and Rehabilitation Associate Professor of Medicine -

More information

Chronic Obstructive Pulmonary Disease Guidelines and updates

Chronic Obstructive Pulmonary Disease Guidelines and updates Chronic Obstructive Pulmonary Disease Guidelines and updates October 20, 2018 Saratoga Springs, NY COPD (Chronic obstructive pulmonary disease) is a major cause of mortality and morbidity in the United

More information

Standardised mortality rates in females and males with COPD and asthma

Standardised mortality rates in females and males with COPD and asthma Eur Respir J 2005; 25: 891 895 DOI: 10.1183/09031936.05.00099204 CopyrightßERS Journals Ltd 2005 Standardised mortality rates in females and males with COPD and asthma T. Ringbaek*, N. Seersholm # and

More information

Chronic obstructive pulmonary disease (COPD) is characterized

Chronic obstructive pulmonary disease (COPD) is characterized DANIEL E. HILLEMAN, PharmD ABSTRACT OBJECTIVE: To review the role of long-acting bronchodilators in the treatment of chronic obstructive pulmonary disease (COPD), including the importance of treatment

More information

PREDICTION EQUATIONS FOR LUNG FUNCTION IN HEALTHY, LIFE TIME NEVER-SMOKING MALAYSIAN POPULATION

PREDICTION EQUATIONS FOR LUNG FUNCTION IN HEALTHY, LIFE TIME NEVER-SMOKING MALAYSIAN POPULATION Prediction Equations for Lung Function in Healthy, Non-smoking Malaysian Population PREDICTION EQUATIONS FOR LUNG FUNCTION IN HEALTHY, LIFE TIME NEVER-SMOKING MALAYSIAN POPULATION Justin Gnanou, Brinnell

More information

E. Prescott + **, P. Lange* +, J. Vestbo**

E. Prescott + **, P. Lange* +, J. Vestbo** Eur Respir J, 1995, 8, 1333 1338 DOI: 10.1183/09031936.95.08081333 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1995 European Respiratory Journal ISSN 0903-1936 Chronic mucus hypersecretion

More information

Respiratory Symptoms and Ventilatory Function in Never- Smoking Males Working in Dusty Occupations

Respiratory Symptoms and Ventilatory Function in Never- Smoking Males Working in Dusty Occupations Open Access Macedonian Journal of Medical Sciences. 2014 Dec 15; 2(4):645-649. http://dx.doi.org/10.3889/oamjms.2014.116 Public Health Respiratory Symptoms and Ventilatory Function in Never- Smoking Males

More information

FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery

FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2010 FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery Nicholas L Mills, David A McAllister, Sarah Wild, John D MacLay,

More information

A Simplified Score to Quantify Comorbidity in COPD

A Simplified Score to Quantify Comorbidity in COPD OPEN ACCESS Citation: Putcha N, Puhan MA, Drummond MB, Han MK, Regan EA, et al. (2014) A Simplified Score to Quantify Comorbidity in COPD. PLoS ONE 9(12): e114438. doi:10.1371/journal.pone. 0114438 Editor:

More information

Association of low income with pulmonary disease progression in smokers with and without chronic obstructive pulmonary disease

Association of low income with pulmonary disease progression in smokers with and without chronic obstructive pulmonary disease ORIGINAL ARTICLE COPD Association of low income with pulmonary disease progression in smokers with and without chronic obstructive pulmonary disease Katherine E. Lowe 1,BarryJ.Make 1, James D. Crapo 1,

More information

aclidinium 322 micrograms inhalation powder (Eklira Genuair ) SMC No. (810/12) Almirall S.A.

aclidinium 322 micrograms inhalation powder (Eklira Genuair ) SMC No. (810/12) Almirall S.A. aclidinium 322 micrograms inhalation powder (Eklira Genuair ) SMC No. (810/12) Almirall S.A. 05 October 2012 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and

More information

Spirometry is the most frequently performed. Obstructive and restrictive spirometric patterns: fixed cut-offs for FEV1/FEV6 and FEV6

Spirometry is the most frequently performed. Obstructive and restrictive spirometric patterns: fixed cut-offs for FEV1/FEV6 and FEV6 Eur Respir J 2006; 27: 378 383 DOI: 10.1183/09031936.06.00036005 CopyrightßERS Journals Ltd 2006 Obstructive and restrictive spirometric patterns: fixed cut-offs for FEV1/ and J. Vandevoorde*, S. Verbanck

More information

ERJ Express. Published on November 14, 2008 as doi: /

ERJ Express. Published on November 14, 2008 as doi: / ERJ Express. Published on November 14, 2008 as doi: 10.1183/09031936.00118808 Occupational Exposures and COPD: An Ecological Analysis of International Data Paul D. Blanc a Ana Maria B. Menezes b Estel

More information